Short answer
Ginkgo Bioworks Holdings, Inc. (DNA) filed an 8-K current report with the SEC on June 12, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Six director nominees elected, preserving board continuity through the next annual meeting.
Ginkgo Bioworks Holdings, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Six director nominees elected, preserving board continuity through the next annual meeting
- Dual-class voting concentrated influence: Class B holders cast 10 votes per share and separately elected Jason Kelly and Reshma Shetty
- Deloitte & Touche ratified for fiscal 2026, with 119,527,721 votes for and 267,727 against
- Executive compensation approved in advisory vote, with 95,058,585 votes for versus 12,502,153 against
- Meeting represented approximately 77.15% of combined voting shares and 93.77% of Class B shares entitled to vote separately
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Ginkgo Bioworks Holdings, Inc. 8-K filings
Get the next DNA 8-K as it lands
Follow DNA for push alerts, or ask the research agent what this filing means.